{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:49:32Z","timestamp":1760100572660},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,3,20]],"date-time":"2013-03-20T00:00:00Z","timestamp":1363737600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Mol Neurosci"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s12031-013-9997-4","type":"journal-article","created":{"date-parts":[[2013,3,19]],"date-time":"2013-03-19T03:36:18Z","timestamp":1363664178000},"page":"360-367","source":"Crossref","is-referenced-by-count":10,"title":["Effect of Genetic Polymorphism +294T\/C in Peroxisome Proliferator-Activated Receptor Delta on the Risk of Ischemic Stroke in a Tunisian Population"],"prefix":"10.1007","volume":"50","author":[{"given":"Khouloud","family":"Chehaibi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Yahia","family":"Hrira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mustapha","family":"Rouis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Najah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imen","family":"Jguirim-Souissi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samir","family":"Nouira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Naceur","family":"Slimane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,3,20]]},"reference":[{"key":"9997_CR1","doi-asserted-by":"crossref","first-page":"108","DOI":"10.7150\/ijms.3.108","volume":"3","author":"J Aberle","year":"2006","unstructured":"Aberle J, Hopfer I, Beil FU, Seedorf U (2006a) Association of the T\u2009+\u2009294C polymorphism in PPAR d with low HDL cholesterol and coronary heart disease risk in women. Int J Med Sci 3:108\u2013111","journal-title":"Int J Med Sci"},{"key":"9997_CR2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1038\/sj.ijo.0803345","volume":"30","author":"J Aberle","year":"2006","unstructured":"Aberle J, Hopfer I, Beil FU, Seedorf U (2006b) Association of peroxisome proliferator-activated receptor delta\u2009+\u2009294\u00a0T\/C with body mass index and interaction with peroxisome proliferator-activated receptor alpha L162V. Int J Obes (Lond) 30:1709\u20131713","journal-title":"Int J Obes (Lond)"},{"key":"9997_CR3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/j.1747-4949.2008.00187.x","volume":"3","author":"CL Allen","year":"2008","unstructured":"Allen CL, Bayraktutan U (2008) Risk factors for ischaemic stroke. Int J Stroke 3:105\u2013116","journal-title":"Int J Stroke"},{"key":"9997_CR4","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/sj.jcbfm.9600200","volume":"26","author":"D Arsenijevic","year":"2006","unstructured":"Arsenijevic D, de Bilbao F, Plamondon J et al (2006) Increased infarct size and lack of hyperphagic response after focal cerebral ischemia in peroxisome proliferator-activated receptor \u03b2-deficient mice. J Cereb Blood Flow Metab 26:433\u2013445","journal-title":"J Cereb Blood Flow Metab"},{"key":"9997_CR5","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1073\/pnas.012610299","volume":"99","author":"Y Barak","year":"2002","unstructured":"Barak Y, Liao D, He W, Ong ES et al (2002) Effects of peroxisome proliferator-activated receptor delta on placentation, adiposity, and colorectal cancer. Proc Natl Acad Sci USA 99:303\u2013308","journal-title":"Proc Natl Acad Sci USA"},{"key":"9997_CR6","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1073\/pnas.0711875105","volume":"105","author":"GD Barish","year":"2008","unstructured":"Barish GD, Atkins AR, Downes M et al (2008) PPAR\u03b4 regulates multiple proinflammatory pathways to suppress atherosclerosis. PNAS 105:4271\u20134276","journal-title":"PNAS"},{"key":"9997_CR7","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1210\/jc.2009-1201","volume":"95","author":"LR Burch","year":"2010","unstructured":"Burch LR, Donnelly LA, Doney ASF et al (2010) Peroxisome Proliferator-Activated Receptor-delta Genotype Influences Metabolic Phenotype and May Influence Lipid Response to Statin Therapy in Humans: A Genetics of Diabetes Audit and Research Tayside Study. J Clin Endocrinol Metab 95:1830\u20131837","journal-title":"J Clin Endocrinol Metab"},{"key":"9997_CR8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S0140-6736(03)12520-2","volume":"361","author":"LR Cardon","year":"2003","unstructured":"Cardon LR, Palmer LJ (2003) Population stratification and spurious allelic association. Lancet 361:598\u2013604","journal-title":"Lancet"},{"key":"9997_CR9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1097\/00008571-200401000-00007","volume":"14","author":"S Chen","year":"2004","unstructured":"Chen S, Tsybouleva N, Ballantyne CM, Gotto AM, Marian AJ (2004) Effects of PPARa, g and d haplotypes on plasma levels of lipids and progression of coronary atherosclerosis and response to statin therapy in the lipoprotein coronary atherosclerosis study. Pharmacogenet 14:61\u201371","journal-title":"Pharmacogenet"},{"key":"9997_CR10","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0140-6736(03)12715-8","volume":"361","author":"HM Colhoun","year":"2003","unstructured":"Colhoun HM, McKeigue PM, Davey SG (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865\u2013872","journal-title":"Lancet"},{"key":"9997_CR11","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1474-4422(07)70028-5","volume":"6","author":"M Dichgans","year":"2007","unstructured":"Dichgans M (2007) Genetics of ischaemic stroke. Lancet Neurol 6:149\u2013161","journal-title":"Lancet Neurol"},{"key":"9997_CR12","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1210\/me.2003-0151","volume":"17","author":"U Dressel","year":"2003","unstructured":"Dressel U, Allen TL, Pippal JB, Rohde PR et al (2003) The peroxisome proliferator-activated receptor beta\/delta agonist, GW501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells. Mol Endocrinol 17:2477\u20132493","journal-title":"Mol Endocrinol"},{"key":"9997_CR13","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1161\/01.STR.0000107187.84390.AA","volume":"35","author":"E Flossmann","year":"2004","unstructured":"Flossmann E, Schulz UG, Rothwell PM (2004) Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35:212\u2013227","journal-title":"Stroke"},{"key":"9997_CR14","first-page":"499","volume":"18","author":"WT Friedewald","year":"1972","unstructured":"Friedewald WT, Levy RI, Fredrickson DS (1972) Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. ClinChem 18:499\u2013502","journal-title":"ClinChem"},{"key":"9997_CR15","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1161\/01.RES.0000060700.55247.7C","volume":"92","author":"AJ Gilde","year":"2003","unstructured":"Gilde AJ, van der Lee KA, Willemsen PH et al (2003) Peroxisome proliferator-activated receptor (PPAR) aandPPARb\/d, but not PPARg, modulate the expression of genes involved in cardiac lipid metabolism. Circ Res 92:518\u2013524","journal-title":"Circ Res"},{"key":"9997_CR16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.atherosclerosis.2005.03.016","volume":"183","author":"I Gouni-Berthold","year":"2005","unstructured":"Gouni-Berthold I, Giannakidou E, Faust M, Berthold HK, Krone W (2005) The peroxisome proliferator-activated receptor delta +294\u00a0T\/C polymorphism in relation to lipoprotein metabolism in patients with diabetes mellitus type 2 and in non-diabetic controls. Atherosclerosis 183:336\u2013341","journal-title":"Atherosclerosis"},{"key":"9997_CR17","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1007\/s00125-007-0668-2","volume":"50","author":"N Grarup","year":"2007","unstructured":"Grarup N, Albrechtsen A, Ek J et al (2007) Variation in the PPAR delta gene in relation to common metabolic traits in 7,495 middle-aged white people. Diabetologia 50:1201\u20131208","journal-title":"Diabetologia"},{"key":"9997_CR18","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1161\/01.STR.0000229883.72010.e4","volume":"37","author":"GJ Hankey","year":"2006","unstructured":"Hankey GJ (2006) Potential new risk factors for ischemic stroke: what is their potential? Stroke 37:2181\u20132188","journal-title":"Stroke"},{"issue":"12","key":"9997_CR19","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1111\/j.1464-5491.2006.02001.x","volume":"23","author":"C Hu","year":"2006","unstructured":"Hu C, Jia W, Fang Q et al (2006) Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects. Diabet Med 23(12):1307\u20131312","journal-title":"Diabet Med"},{"key":"9997_CR20","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.cmet.2008.03.010","volume":"7","author":"C Iadecola","year":"2008","unstructured":"Iadecola C, Davisson RL (2008) Hypertension and cerebrovascular dysfunction. Cell Metab 7:476\u2013484","journal-title":"Cell Metab"},{"key":"9997_CR21","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1124\/jpet.106.115758","volume":"320","author":"A Iwashita","year":"2007","unstructured":"Iwashita A, Muramatsu Y, Yamazaki T et al (2007) Neuroprotective efficacy of the peroxisome proliferators-activated receptor delta selective agonists in vitro and in vivo. J Pharmacol Exp Ther 320:1087\u20131096","journal-title":"J Pharmacol Exp Ther"},{"key":"9997_CR22","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.4238\/vol9-3gmr831","volume":"9","author":"I Jguirim-Souissi","year":"2010","unstructured":"Jguirim-Souissi I, Jelassi A, Hrira Y et al (2010) + 294\u00a0T\/C polymorphism in the PPAR- d gene is associated with risk of coronary artery disease in normolipidemic Tunisians. Genet Mol Res 9:1326\u20131333","journal-title":"Genet Mol Res"},{"key":"9997_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1161\/CIRCRESAHA.108.189159","volume":"105","author":"HJ Kim","year":"2009","unstructured":"Kim HJ, Kim MY, Jin et al (2009) Peroxisome proliferator-activated receptor delta regulates extracellular matrix and apoptosis of vascular smooth muscle cells through the activation of transforming growth factor-{beta}1\/ Smad3. Circ Res 105:16\u201324","journal-title":"Circ Res"},{"key":"9997_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jns.2008.12.012","volume":"279","author":"HS Kirshner","year":"2009","unstructured":"Kirshner HS (2009) Differentiating ischemic stroke subtypes: risk factors and secondary prevention. J Neurol Sci 279:1\u20138","journal-title":"J Neurol Sci"},{"key":"9997_CR25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1126\/science.1087344","volume":"302","author":"CH Lee","year":"2003","unstructured":"Lee CH, Chawla A, Urbiztondo N et al (2003) Transcriptional repression of atherogenic inflammation: modulation by PPAR\u03b4. Science 302:453\u2013457","journal-title":"Science"},{"key":"9997_CR26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S0014-5793(00)01554-4","volume":"473","author":"MD Leibowitz","year":"2000","unstructured":"Leibowitz MD, Fievet C, Hennuyer N, Peinado-Onsurbe J et al (2000) Activation of PPARdelta alters lipid metabolism in db\/db mice. FEBS Lett 473:333\u2013336","journal-title":"FEBS Lett"},{"key":"9997_CR27","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1161\/01.ATV.0000223875.14120.93","volume":"26","author":"JY Liou","year":"2006","unstructured":"Liou JY, Lee S, Ghelani D et al (2006) Protection of endothelial survival by peroxisome proliferator-activated receptor-delta mediated 14-3-3 upregulation. Arterioscler Thromb Vasc Biol 26:1481\u20131487","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"9997_CR28","doi-asserted-by":"crossref","first-page":"e34895","DOI":"10.1371\/journal.pone.0034895","volume":"7","author":"L Lu","year":"2012","unstructured":"Lu L, Wu Y, Qi Q et al (2012) Associations of Type 2 Diabetes with Common Variants in PPARD and the Modifying Effect of Vitamin D among Middle-Aged and Elderly Chinese. PLoS One 7(4):e34895","journal-title":"PLoS One"},{"key":"9997_CR29","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1083\/jcb.200011148","volume":"154","author":"L Michalik","year":"2001","unstructured":"Michalik L, Desvergne B, Tan NS et al (2001) Impaired skin wound healing in peroxisome proliferator-activated receptor (PPAR) alpha and PPARbeta mutant mice. J Cell Biol 154:799\u2013814","journal-title":"J Cell Biol"},{"key":"9997_CR30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s00380-009-1159-9","volume":"25","author":"AG Nikitin","year":"2010","unstructured":"Nikitin AG, Chistiakov DA, Minushkina LO, Zateyshchikov DA, Nosikov VV (2010) Association of the CYBA, PPARGC1A, PPARG3, and PPARD gene variants with coronary artery disease and metabolic risk factors of coronary atherosclerosis in a Russian population. Hear Vessel 25:229\u2013236","journal-title":"Hear Vessel"},{"key":"9997_CR31","doi-asserted-by":"crossref","first-page":"5306","DOI":"10.1073\/pnas.091021198","volume":"98","author":"WR Oliver","year":"2001","unstructured":"Oliver WR, Shenk JL, Snaith MR et al (2001) A selective peroxisome proliferator-activated receptor d agonist promotes reverse cholesterol transport. Proc Natl Acad Sci USA 98:5306\u20135311","journal-title":"Proc Natl Acad Sci USA"},{"key":"9997_CR32","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1128\/MCB.20.14.5119-5128.2000","volume":"20","author":"JM Peters","year":"2000","unstructured":"Peters JM, Lee SS, Li W et al (2000) Growth, adipose, brain, and skin alterations resulting from targeted disruption of the mouse peroxisome proliferator-activated receptor beta (delta). Mol Cell Biol 20:5119\u20135128","journal-title":"Mol Cell Biol"},{"key":"9997_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/nbm.1157","volume":"20","author":"JB Pialat","year":"2007","unstructured":"Pialat JB, Cho TH, Beuf O et al (2007) MRI monitoring of focal cerebral ischemia in peroxisome proliferator-activated receptor (PPAR)-deficient mice. NMR Biomed 20:335\u2013342","journal-title":"NMR Biomed"},{"key":"9997_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1161\/01.ATV.0000250972.83623.61","volume":"27","author":"L Piqueras","year":"2007","unstructured":"Piqueras L, Reynolds AR, Hodivala-Dilke KM et al (2007) Activation of PPARbeta\/delta induces endothelial cell proliferation and angiogenesis. Arterioscler Thromb Vasc Biol 27:63\u201369","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9997_CR35","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0014-2999(01)01589-8","volume":"435","author":"Y Rival","year":"2002","unstructured":"Rival Y, Beneteau N, Taillandier T et al (2002) PPARalpha and PPARdelta activators inhibit cytokine-induced nuclear translocation of NF-kappaB and expression of VCAM-1 in EAhy926 endothelial cells. Eur J Pharmacol 435:143\u2013151","journal-title":"Eur J Pharmacol"},{"key":"9997_CR36","doi-asserted-by":"crossref","unstructured":"Robitaille J, Gaudet D, Perusse L, Vohl MC (2006 Sep 5). Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator-activated receptor-delta - 87T>C polymorphism and dietary fat in French-Canadians. Int J Obes (Lond)","DOI":"10.1038\/sj.ijo.0803450"},{"key":"9997_CR37","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/sj.ijo.0803450","volume":"31","author":"J Robitaille","year":"2007","unstructured":"Robitaille J, Gaudet D, P\u00e9russe L, Vohl MC (2007) Features of the metabolic syndrome are modulated by an interaction between the peroxisome proliferator activated receptor-delta - 87T>C polymorphism and dietary fat in French-Canadians. Int J Obes (Lond) 31:411\u2013417","journal-title":"Int J Obes (Lond)"},{"key":"9997_CR38","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1161\/01.STR.0000079818.08343.8C","volume":"34","author":"UG Schulz","year":"2003","unstructured":"Schulz UG, Rothwell PM (2003) Differences in vascular risk factors between etiological subtypes of ischemic stroke: importance of population-based studies. Stroke 34:2050\u20132059","journal-title":"Stroke"},{"key":"9997_CR39","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1073\/pnas.052707099","volume":"99","author":"Y Shi","year":"2002","unstructured":"Shi Y, Hon M, Evans RM (2002) The peroxisome proliferator-activated receptor delta, an integrator of transcriptional repression and nuclear receptor signaling. Proc Natl Acad Sci USA 99:2613\u20132618","journal-title":"Proc Natl Acad Sci USA"},{"issue":"3","key":"9997_CR40","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/diabetes.53.3.847","volume":"53","author":"HD Shin","year":"2004","unstructured":"Shin HD, Park BL, Kim LH et al (2004) Genetic polymorphisms in peroxisome proliferator-activated receptor delta associated with obesity. Diabetes 53(3):847\u2013851","journal-title":"Diabetes"},{"key":"9997_CR41","first-page":"73","volume":"6","author":"J Skogsberg","year":"2000","unstructured":"Skogsberg J, Kannisto K, Roshani L et al (2000) Characterization of the human peroxisome proliferator activated receptor delta gene and its expression. Int J Mol Med 6:73\u201381","journal-title":"Int J Mol Med"},{"key":"9997_CR42","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1161\/01.ATV.0000064383.88696.24","volume":"23","author":"J Skogsberg","year":"2003","unstructured":"Skogsberg J, Kannisto K, Cassel TN, Hamsten A et al (2003a) Evidence that peroxisome proliferator-activated receptor delta influences cholesterol metabolism in men. Arterioscler Thromb Vasc Biol 23:637\u2013643","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9997_CR43","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1111\/j.1365-2796.2003.01236.x","volume":"254","author":"J Skogsberg","year":"2003","unstructured":"Skogsberg J, McMahon AD, Karpe F, Hamsten A et al (2003b) Peroxisome proliferator activated receptor delta genotype in relation to cardiovascular risk factors and risk of coronary heart disease in hypercholesterolaemic men. J Intern Med 254:597\u2013604","journal-title":"J Intern Med"},{"key":"9997_CR44","doi-asserted-by":"crossref","first-page":"3263","DOI":"10.1101\/gad.207501","volume":"15","author":"NS Tan","year":"2001","unstructured":"Tan NS, Michalik L, Noy N, Yasmin R et al (2001) Critical roles of PPAR beta\/delta in keratinocyte response to inflammation. Genes Dev 15:3263\u20133277","journal-title":"Genes Dev"},{"key":"9997_CR45","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1042\/bst0320097","volume":"32","author":"NS Tan","year":"2004","unstructured":"Tan NS, Michalik L, Di-Poi N, Desvergne B et al (2004) Critical roles of the nuclear receptor PPARbeta (peroxisome-proliferator-activated receptor beta) in skin wound healing. Biochem Soc Trans 32:97\u2013102","journal-title":"Biochem Soc Trans"},{"issue":"Suppl. 1","key":"9997_CR46","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.21.1.S5","volume":"22","author":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus ADA","year":"1998","unstructured":"The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus ADA (1998) Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 22( Suppl. 1):S5\u2013S19","journal-title":"Diabetes Care"},{"issue":"5","key":"9997_CR47","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1111\/j.1469-1809.2011.00669.x","volume":"75","author":"R Villegas","year":"2011","unstructured":"Villegas R, Williams S, Gao Y et al (2011) Variation and type 2 diabetes in middle age Chinese women. Ann Hum Genet 75(5):621\u2013629","journal-title":"Ann Hum Genet"},{"key":"9997_CR48","doi-asserted-by":"crossref","first-page":"44258","DOI":"10.1074\/jbc.M108482200","volume":"276","author":"H Vosper","year":"2001","unstructured":"Vosper H, Patel L, Graham TL et al (2001) The peroxisome proliferator-activated receptor_ promotes lipid accumulation in human macrophages. J Biol Chem 276:44258\u201344265","journal-title":"J Biol Chem"},{"issue":"10","key":"9997_CR49","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1371\/journal.pbio.0020294","volume":"2","author":"YX Wang","year":"2004","unstructured":"Wang YX, Zhang CL, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR et al (2004) Regulation of muscle fiber type and running endurance by PPARdelta. PLoS Biol 2(10):294","journal-title":"PLoS Biol"},{"key":"9997_CR50","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/1476-511X-10-242","volume":"10","author":"X-L Wei","year":"2011","unstructured":"Wei X-L, Yin R-X, Miao L, Wu D-F (2011) The peroxisome proliferator-activated receptor delta +294T>C polymorphism and alcohol consumption on serum lipid levels. Lipids Health Dis 10:242","journal-title":"Lipids Health Dis"},{"key":"9997_CR51","doi-asserted-by":"crossref","first-page":"6712","DOI":"10.1073\/pnas.1031789100","volume":"100","author":"JS Welch","year":"2003","unstructured":"Welch JS, Ricote M, Akiyama TE et al (2003) PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages. Proc Natl Acad Sci U S A 100:6712\u20136717","journal-title":"Proc Natl Acad Sci U S A"},{"key":"9997_CR52","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s11010-011-0987-y","volume":"358","author":"H Yilmaz-Aydogan","year":"2011","unstructured":"Yilmaz-Aydogan H, Kurnaz O, Kurt O et al (2011) Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes. Mol Cell Biochem 358:355\u2013363","journal-title":"Mol Cell Biochem"},{"key":"9997_CR53","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1089\/dna.2011.1464","volume":"31","author":"H Y\u0131lmaz-Aydogan","year":"2012","unstructured":"Y\u0131lmaz-Aydogan H, Kucukhuseyin O, Kurnaz O et al (2012) Investigation of polymorphic variants of PPARD and APOE Genes in Turkish Coronary Heart Disease Patients. DNA Cell Biol 31:867\u2013875","journal-title":"DNA Cell Biol"},{"key":"9997_CR54","doi-asserted-by":"crossref","first-page":"6398","DOI":"10.1523\/JNEUROSCI.0780-10.2010","volume":"30","author":"KJ Yin","year":"2010","unstructured":"Yin KJ, Deng Z, Hamblin M et al (2010) Peroxisome proliferator-activated receptor delta regulation of mir-15a in ischemia-induced cerebral vascular endothelial injury. J Neurosci 30:6398\u20136408","journal-title":"J Neurosci"},{"key":"9997_CR55","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1161\/ATVBAHA.110.221267","volume":"31","author":"KJ Yin","year":"2011","unstructured":"Yin KJ, Zhen D, Milton H, Jifeng Z, Chen EY (2011) Vascular PPAR\u03b4 protects against stroke-induced brain injury. Arterioscler Thromb Vasc Biol 31:574\u2013581","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Journal of Molecular Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-9997-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12031-013-9997-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12031-013-9997-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,10]],"date-time":"2019-07-10T23:30:58Z","timestamp":1562801458000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12031-013-9997-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,3,20]]},"references-count":55,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["9997"],"URL":"https:\/\/doi.org\/10.1007\/s12031-013-9997-4","relation":{},"ISSN":["0895-8696","1559-1166"],"issn-type":[{"value":"0895-8696","type":"print"},{"value":"1559-1166","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,3,20]]}}}